Elasmogen is Drug Discovery in United Kingdom that focus on inflammatory conditions business. Founded in 2014. They cover business area such as Provider, biopharmaceutical service, solid-tumor cancer, systemic inflammatory disease, inflammatory condition, treatment, auto-immune-mediate, inflammatory disease, biologic, drug, small, simple, and stable format, site-specific delivery, patient, therapy.
2014
( 10 years old in 2024 )
Inflammatory Conditions
-
Liberty Building
Foresterhill Health Campus
Aberdeen AB25 2ZP
Scotland, United Kingdom
Private
Providerbiopharmaceutical servicesolid-tumor cancersystemic inflammatory diseaseinflammatory conditiontreatmentauto-immune-mediate, inflammatory diseasebiologicdrugsmall, simple, and stable formatsite-specific deliverypatienttherapy
* We use standard office opening hours in near Elasmogen's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Elasmogen is Drug Discovery business from United Kingdom that founded in 2014 (10 years old in 2024), Elasmogen business is focusing on Inflammatory Conditions.
Elasmogen headquarter office and corporate office address is located in Liberty Building Foresterhill Health Campus Aberdeen AB25 2ZP Scotland, United Kingdom.
Elasmogen was founded in United Kingdom.
In 2024, Elasmogen is currently focus on inflammatory conditions sector.
Above is snippet of Google Trends for "inflammatory conditions" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Elasmogen, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
